Ulf Bladin
Prolight Diagnostics receives positive feedback at ADLM Congress
Prolight Diagnostics recently participated at the ADLM congress in Chicago, where the company had the opportunity to present its...
Prolights Diagnostics CEO: "We continue to deliver what we promise"
Prolight Diagnostics CEO Ulf Bladin visited BioStock's studio...
Prolights Diagnostics CTO delighted to receive UK government grant
The NIHR i4i Product Development Award has been awarded to Prolight...
Prolight Diagnostics CTO highlights the potential of Psyros
BioStock interviews Steve Ross, co-founder of Psyros Diagnostics...
Prolight Diagnostics CEO: "We deliver on all goals"
Prolight Diagnostics' year-end report for 2023 shows that the company...
Prolight Diagnostics CEO comments on the issue outcome
Prolight Diagnostics recently announced the outcome of the rights issue that...
Prolight's CEO: "It will significantly improve patient flow"
Prolight Diagnostics CEO Ulf Bladin visited BioStock's studio...
BioStock Investor Pitch: Prolight Diagnostics
Prolight Diagnostics is developing a new patient-facing analysis system, Psyros,...
Prolight Diagnostics CEO: "We are accelerating towards launch"
When Prolight Diagnostics acquired Psyros Diagnostics last year...
Prolight's CEO: "Proof-of-Performance in thoroughbreds important milestone"
Prolight Diagnostics has demonstrated Proof-of-Performance in whole blood for...
The five best life science stocks of the first half of the year
Ahead of 2023, many investors and company managements hoped for...
BioStock Studio: Prolight Diagnostics regarding focus areas for 2022
Ulf Bladin, CEO of Prolight Diagnostics, visited BioStocks...
Notes
Mentice consolidates operations to Denver
Bio-Works secures million-dollar order from global pharmaceutical company
OncoZenge receives investment proceeds from Yangtian Bio-Pharmaceutical
Xspray Pharma confirms bioequivalence for XS003
Evaxion converts debt of EUR 3,5 million
NEWSLETTER
NEWS
AI-designed proteins are created in seconds
The price of Leqembi needs to be lowered in Japan
Merck gears up in lung diseases with giant acquisition
Upcoming events!
Investing in Life Science
Discover unparalleled opportunities, set in the vibrant heart of Stockholm. This premier event unites forward-thinking investors and business leaders to...
Life Science Summit
The Nordic region's leading forum for early-stage and growth-phase life science companies. The Summit bridges innovation and capital by providing...
You deserve the best!
Unlock our premium content: Become a subscriber!
Create Account
Chronicles
The market is taking Trump's tariff threat in stride
The EU's new life science strategy – a step in the right direction or just fluff?
